Trials that use: Mixed-effects model
New to this method? Read the tutorial →
279 results
- A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington’s Disease (HD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Effect of SAGE-718 on Cognitive Function in Participants With Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate with confidence interval,…
- A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control With Diet and Exercise: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Effectiveness, Safety, and Tolerability of Canagliflozin in Combination With Metformin in the Treatment of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic…
- A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE): Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma: primary endpoint results,…
- A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma:…
- A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR Mutation: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of VX-661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Heterozygous for the F508del-CFTR…
- A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee: primary endpoint results, effect estimate…
- A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants: Complete Statistical AnalysisIndependent statistical analysis of A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF): Complete Statistical AnalysisIndependent statistical analysis of A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD): Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Efficacy and Safety of Balovaptan (RO5285119) in Participants With Autism Spectrum Disorder (ASD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Efficacy and Safety of GSK3196165 in Inflammatory Hand Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on Stable Antipsychotic Treatment.: Complete Statistical AnalysisIndependent statistical analysis of A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks in Patients With Schizophrenia on…
- A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia: primary endpoint results, effect estimate with…
- A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF): Complete Statistical AnalysisIndependent statistical analysis of A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF): primary endpoint results, effect estimate with confidence…
- A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease: primary endpoint results,…
- ABATEIndependent statistical analysis of Active Bathing to Eliminate Infection (ABATE Infection) Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02063867).
- Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: Complete Statistical AnalysisIndependent statistical analysis of Academic Stress and Proinflammatory Cytokines: Omega-3 Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00519779).
- ACTIVEIndependent statistical analysis of ACTIVE: Advanced Cognitive Training for Independent and Vital Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298558).
- Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Participants Aged 7 to 11 Years With Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval,…
- ADJUNCT ONE™Complete statistical analysis of the phase 3 ADJUNCT ONE™ trial of liraglutide as adjunct therapy to insulin in type 1 diabetes, including non-inferiority analysis of HbA1c, body-weight and insulin-dose results, hypoglycemia, methodology,…
- AESOPS-T1Independent statistical analysis of Application of Economics & Social Psychology to Improve Opioid Prescribing Safety Trial 1: EHR Nudges: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ALIGN: Aligning Medications With What Matters Most (Demonstration): Complete Statistical AnalysisIndependent statistical analysis of ALIGN: Aligning Medications With What Matters Most (Demonstration): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06335953).
- AMARANTHComplete statistical analysis of the AMARANTH phase 2/3 trial of lanabecestat in early Alzheimer's disease, including trial design, primary and secondary endpoint results, ANCOVA and mixed-effects methodology, safety, and statistical interpretation.
- An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Complete Statistical AnalysisIndependent statistical analysis of An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions: Complete Statistical AnalysisIndependent statistical analysis of An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD: Complete Statistical AnalysisIndependent statistical analysis of An Integrated Nutrition Intervention to Promote Healthy Eating Habits for Children With ASD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Ancillary Study of the Lessening Incontinence With Low-impact Activity Study: Complete Statistical AnalysisIndependent statistical analysis of Ancillary Study of the Lessening Incontinence With Low-impact Activity Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04776720).
- Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Anti-Inflammatory Small Drug Adjunctive Therapy for Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02597101).
- Antidepressant Effects of TS-161 in Treatment-Resistant Depression: Complete Statistical AnalysisIndependent statistical analysis of Antidepressant Effects of TS-161 in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04821271).
- APOLLOIndependent statistical analysis of Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB: primary endpoint results, effect estimate with confidence interval, sample-size…
- ASCENDIndependent statistical analysis of Assessing Symptomatic Clinical Episodes in Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03595579).
- AscenD-LBIndependent statistical analysis of Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ASCLEPIOS IAn independent statistical analysis of ASCLEPIOS I, the phase 3 double-blind comparison of ofatumumab and teriflunomide in relapsing multiple sclerosis, covering the negative binomial relapse-rate analysis, Cox models for pooled disability endpoints,…
- ASCLEPIOS IIAn independent statistical analysis of ASCLEPIOS II, the phase 3 trial of subcutaneous ofatumumab versus teriflunomide in relapsing multiple sclerosis: negative binomial annualized relapse rate, Cox models for confirmed disability, pooled analyses…
- ASPIREIndependent statistical analysis of Coaching Veterans to Healthy Weights and Wellness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00967668).
- Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: Complete Statistical AnalysisIndependent statistical analysis of Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- AtazanavirIndependent statistical analysis of Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With Cobicistat: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- ATTAIN-1Complete statistical analysis of ATTAIN-1, a randomized phase 3 trial of orforglipron in adults with obesity or overweight with weight-related comorbidities, including its mixed-effects methodology, primary weight endpoint, secondary metabolic outcomes, safety,…
- ATTRibute-CMIndependent statistical analysis of Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- AutonomyIndependent statistical analysis of A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04619420).
- AVALLIndependent statistical analysis of Assessment of an School-based Intervention in Eating Habits and Physical Activity in Schoolchildren: the AVall Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- AWARD-6Independent statistical analysis of the randomized phase 3 AWARD-6 trial comparing dulaglutide with liraglutide in type 2 diabetes, including the HbA1c non-inferiority analysis, secondary endpoints, statistical methods, safety, and interpretation.
- AWARD-CHN3Independent statistical analysis of A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…